Professor Sir Ed Southern, founder of Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has been awarded the 2011 Medical Research Council (MRC) Millennium Medal.
30 January, 2012
Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology.
23 January, 2012
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
23 January, 2012
Pain therapy drug developers address the rapid rise in prescription drug abuse alongside the need for safe and effective treatments for a growing number of chronic pain sufferers. The sector has a diverse pipeline, with reformulations of existing therapies and alternative modes of drug delivery in development alongside novel compounds. However, increased generic competition will temper market growth over the next decade.
23 January, 2012
Despite the doom and gloom surrounding the pharmaceutical industry and the many commentaries highlighting inefficiencies of the sectors operating model, 2011 has proven to be a near-record year for approvals of innovative new drugs. These approvals include seven new cancer treatments with two of these (Pfizer’s crizotinib, Xalkori™ and Roche’s vemurafenib, Zelboraf™) made in conjunction with companion genetic tests, reinforcing the notion that the practice of stratified medicine has truly arrived. The forthcoming special issue of Drug Discovery Today on cancer highlights innovative contributions in basic, translational and clinical research made by UK scientists and clinicians in the fight against cancer.
23 January, 2012
Development charity Sightsavers has today unveiled a 10-year campaign to help eliminate one of the world’s leading causes of preventable blindness, termed onchocerciasis (also river blindness). With plans to fundraise and invest more than £27 million over the next decade to help combat this neglected tropical disease (NTD) across Africa, the charity is starting work this month in the Democratic Republic of the Congo where the disease is endemic.
17 January, 2012
BioCity Scotland Ltd, a joint venture between BioCity Nottingham and Roslin BioCentre, has today announced the acquisition of the former-MSD research facility at Newhouse, Lanarkshire. This exciting deal will enable the development of a dedicated base in central Scotland for growing bioscience, pharmaceutical, med tech and healthcare companies.
11 January, 2012
Scientists based at Cancer Research UK’s Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature.
05 January, 2012